These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 15989956

  • 21. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ, Zhu MH, Ni CR, Li FM, Zheng JM, Gong ZJ.
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [Abstract] [Full Text] [Related]

  • 22. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
    Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W.
    Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
    [Abstract] [Full Text] [Related]

  • 23. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM.
    Nature; 2004 May 06; 429(6987):86-92. PubMed ID: 15103385
    [Abstract] [Full Text] [Related]

  • 24. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL, Gu W.
    Cell Cycle; 2004 Jul 06; 3(7):895-9. PubMed ID: 15254415
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse Iii HC.
    Int J Mol Sci; 2012 Jul 06; 13(5):6204-6219. PubMed ID: 22754359
    [Abstract] [Full Text] [Related]

  • 27. Expression of p14ARF overcomes tumor resistance to p53.
    Lu W, Lin J, Chen J.
    Cancer Res; 2002 Mar 01; 62(5):1305-10. PubMed ID: 11888896
    [Abstract] [Full Text] [Related]

  • 28. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
    Inoue S, Hao Z, Elia AJ, Cescon D, Zhou L, Silvester J, Snow B, Harris IS, Sasaki M, Li WY, Itsumi M, Yamamoto K, Ueda T, Dominguez-Brauer C, Gorrini C, Chio II, Haight J, You-Ten A, McCracken S, Wakeham A, Ghazarian D, Penn LJ, Melino G, Mak TW.
    Genes Dev; 2013 May 15; 27(10):1101-14. PubMed ID: 23699408
    [Abstract] [Full Text] [Related]

  • 29. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW.
    J Mol Biol; 2001 Nov 23; 314(2):263-77. PubMed ID: 11718560
    [Abstract] [Full Text] [Related]

  • 30. Regulation of human p53 activity and cell localization by alternative splicing.
    Ghosh A, Stewart D, Matlashewski G.
    Mol Cell Biol; 2004 Sep 23; 24(18):7987-97. PubMed ID: 15340061
    [Abstract] [Full Text] [Related]

  • 31. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
    Li Z, Hou J, Sun L, Wen T, Wang L, Zhao X, Xie Q, Zhang SQ.
    Mol Biol Cell; 2012 Dec 23; 23(23):4635-46. PubMed ID: 23034180
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF, Villuendas R, Sánchez-Beato M, Sánchez-Aguilera A, Sánchez L, Prieto I, Piris MA.
    Am J Pathol; 2002 Feb 23; 160(2):569-78. PubMed ID: 11839577
    [Abstract] [Full Text] [Related]

  • 34. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M, Sun Y.
    Anticancer Res; 2003 Feb 23; 23(4):3167-74. PubMed ID: 12926050
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
    Wang X, Zha M, Zhao X, Jiang P, Du W, Tam AY, Mei Y, Wu M.
    Nat Commun; 2013 Feb 23; 4():1551. PubMed ID: 23462994
    [Abstract] [Full Text] [Related]

  • 37. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
    Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ.
    Proc Natl Acad Sci U S A; 1998 Jul 07; 95(14):8292-7. PubMed ID: 9653180
    [Abstract] [Full Text] [Related]

  • 38. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
    Lohrum MA, Ashcroft M, Kubbutat MH, Vousden KH.
    Curr Biol; 2000 May 04; 10(9):539-42. PubMed ID: 10801444
    [Abstract] [Full Text] [Related]

  • 39. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.
    Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y.
    Mol Cell; 2003 Nov 04; 12(5):1151-64. PubMed ID: 14636574
    [Abstract] [Full Text] [Related]

  • 40. Decreased Mdm2 expression inhibits tumor development induced by loss of ARF.
    Wang P, Greiner TC, Lushnikova T, Eischen CM.
    Oncogene; 2006 Jun 22; 25(26):3708-18. PubMed ID: 16491126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.